Galapagos NV (GLPG)
NASDAQ: GLPG · Real-Time Price · USD
28.83
+0.28 (0.98%)
At close: Jul 3, 2025, 4:00 PM
28.83
0.00 (0.00%)
After-hours: Jul 3, 2025, 1:00 PM EDT
Galapagos NV Market Cap
Galapagos NV has a market cap or net worth of $1.90 billion as of July 3, 2025. Its market cap has increased by 13.55% in one year.
Market Cap
1.90B
Enterprise Value
-1.96B
1-Year Change
13.55%
Ranking
Category
Stock Price
$28.83
Market Cap Chart
Since May 14, 2015, Galapagos NV's market cap has increased from $1.86B to $1.90B, an increase of 2.17%. That is a compound annual growth rate of 0.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2025 | 1.88B | 3.82% |
| Dec 31, 2024 | 1.81B | -32.28% |
| Dec 29, 2023 | 2.68B | -8.14% |
| Dec 30, 2022 | 2.91B | -19.35% |
| Dec 31, 2021 | 3.61B | -43.56% |
| Dec 31, 2020 | 6.40B | -43.18% |
| Dec 31, 2019 | 11.27B | 141.07% |
| Dec 31, 2018 | 4.67B | 7.74% |
| Dec 29, 2017 | 4.34B | 72.91% |
| Dec 30, 2016 | 2.51B | 8.12% |
| Dec 31, 2015 | 2.32B | 24.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.62B |
| Johnson & Johnson | 373.81B |
| AbbVie | 336.45B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 281.03B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 233.90B |
| AstraZeneca | 219.33B |